Verano Holdings (VRNO) Capital Expenditures (2021 - 2026)

Verano Holdings' (VRNO) quarterly Capital Expenditures came in at $14.9 million in Q1 2026, up 7.74% year-on-year from $13.9 million in Q1 2025, and up 58.33% on a QoQ basis from $9.4 million in Q4 2025.

Verano Holdings (VRNO) Capital Expenditures (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Capital Expenditures data on file, last reported at $14.9 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 7.74% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $42.3 million, a 59.02% decrease from a year earlier, with the FY2025 full-year figure at $41.2 million, down 58.38% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $14.9 million, up from $9.4 million in the prior quarter.
  • Over the last five years, Capital Expenditures for VRNO reached as high as $106.4 million in Q3 2022 and fell as low as -$103.7 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $9.8 million across 5 years, with a median of $10.0 million in 2023.
  • Across the five-year window, Capital Expenditures tumbled 310.31% in 2022 and jumped 468.04% in 2024, its largest moves.
  • Year by year, Capital Expenditures stood at -$103.7 million in 2022, then surged by 79.19% to -$21.6 million in 2023, then jumped by 165.99% to $14.2 million in 2024, then tumbled by 33.77% to $9.4 million in 2025, then surged by 58.33% to $14.9 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $14.9 million in Q1 2026, $9.4 million in Q4 2025, and $7.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 14.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.94 Mn
Mar 31, 2026 14.94 Mn
Dec 31, 2025 9.43 Mn
Dec 31, 2025 9.43 Mn
Sep 30, 2025 7.46 Mn
Sep 30, 2025 7.46 Mn
Jun 30, 2025 10.47 Mn
Jun 30, 2025 10.47 Mn
Mar 31, 2025 13.86 Mn
Mar 31, 2025 13.86 Mn
Dec 31, 2024 14.25 Mn
Dec 31, 2024 14.25 Mn
Sep 30, 2024 56.59 Mn
Sep 30, 2024 56.59 Mn
Jun 30, 2024 18.52 Mn
Jun 30, 2024 18.52 Mn
Mar 31, 2024 9.70 Mn
Mar 31, 2024 9.70 Mn
Dec 31, 2023 -21.59 Mn
Dec 31, 2023 -21.59 Mn